Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Lung Cancer Patients ◽

Lymphocyte To Monocyte Ratio ◽

Epidermal Growth ◽

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Medicine ◽

10.1097/md.0000000000002239 ◽

2015 ◽

Vol 94 (50) ◽

pp. e2239 ◽

Cited By ~ 4

Author(s):

Yu-Mu Chen ◽

Chien-Hao Lai ◽

Huang-Chih Chang ◽

Tung-Ying Chao ◽

Chia-Cheng Tseng ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

First Line ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

450P Impact of baseline, trend, and normalization of carcinoembryonic antigen on survival in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors

Annals of Oncology ◽

10.1093/annonc/mdv532.34 ◽

2015 ◽

Vol 26 ◽

pp. ix125

Author(s):

Y.-M. Chen ◽

C.-H. Lai ◽

M.-C. Lin

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

First Line ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

PLoS ONE ◽

10.1371/journal.pone.0149722 ◽

2016 ◽

Vol 11 (2) ◽

pp. e0149722 ◽

Cited By ~ 8

Author(s):

Yu-Mu Chen ◽

Chien-Hao Lai ◽

Huang-Chih Chang ◽

Tung-Ying Chao ◽

Chia-Cheng Tseng ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

First Generation ◽

Kinase Inhibitors ◽

De Novo ◽

Growth Factor Receptor ◽

First Line ◽

Epidermal Growth ◽

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

BMC Cancer ◽

10.1186/s12885-016-2917-6 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 2

Author(s):

Yu-Mu Chen ◽

Chien-Hao Lai ◽

Kun-Ming Rau ◽

Cheng-Hua Huang ◽

Huang-Chih Chang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Lung Cancer Patients ◽

Inflammatory Status ◽

Epidermal Growth ◽

Urinary and Plasma Cell-Free DNA Comparison for Lung Cancer Patients Treated With Epidermal Growth Factor Receptor—Thyroxine Kinase Inhibitors

The American Journal of the Medical Sciences ◽

10.1016/j.amjms.2018.10.006 ◽

2019 ◽

Vol 357 (1) ◽

pp. 29-36 ◽

Cited By ~ 2

Author(s):

Haiying Yu ◽

Mei Liu ◽

Huibing Qiu ◽

Kai Yang

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Lung Cancer Patients ◽

Free Dna ◽

Epidermal Growth

Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients

Indian Journal of Cancer ◽

10.4103/ijc.ijc_532_17 ◽

2017 ◽

Vol 54 (5) ◽

pp. 37 ◽

Cited By ~ 3

Author(s):

U Batra ◽

N Lokeshwar ◽

S Gupta ◽

P Shirsath

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Nonsmall Cell Lung Cancer ◽

Lung Cancer Patients ◽

Epidermal Growth

Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2016.01.003 ◽

2016 ◽

Vol 93 ◽

pp. 59-68 ◽

Cited By ~ 71

Author(s):

Chee-Seng Tan ◽

Byoung-Chul Cho ◽

Ross A. Soo

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer

Cancer ◽

10.1002/cncr.29397 ◽

2015 ◽

Vol 121 (15) ◽

pp. 2570-2577 ◽

Cited By ~ 24

Author(s):

Peter C. Lo ◽

Suzanne E. Dahlberg ◽

Mizuki Nishino ◽

Bruce E. Johnson ◽

Lecia V. Sequist ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

First Line ◽

Treatment Change ◽

Epidermal Growth ◽

Receptor Mutant ◽

Delay Of Treatment

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Metastatic to the Brain

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-2529 ◽

2011 ◽

Vol 18 (4) ◽

pp. 938-944 ◽

Cited By ~ 105

Author(s):

Mariam Jamal-Hanjani ◽

James Spicer

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant ◽

The Brain

FEASIBILITY AND CLINICAL IMPACT OF RE-BIOPSY IN ADVANCED LUNG ADENOCARCINOMA AFTER PROGRESSES DURING FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS

Respirology ◽

10.1111/resp.13419_13 ◽

2018 ◽

Vol 23 ◽

pp. 9-9

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase Inhibitors

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Clinical Impact ◽

First Line ◽

Epidermal Growth ◽